1. Home
  2. CRBU vs ACU Comparison

CRBU vs ACU Comparison

Compare CRBU & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • ACU
  • Stock Information
  • Founded
  • CRBU 2011
  • ACU 1867
  • Country
  • CRBU United States
  • ACU United States
  • Employees
  • CRBU N/A
  • ACU N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • ACU Industrial Machinery/Components
  • Sector
  • CRBU Health Care
  • ACU Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • ACU Nasdaq
  • Market Cap
  • CRBU 151.2M
  • ACU 167.6M
  • IPO Year
  • CRBU 2021
  • ACU N/A
  • Fundamental
  • Price
  • CRBU $1.52
  • ACU $37.50
  • Analyst Decision
  • CRBU Strong Buy
  • ACU
  • Analyst Count
  • CRBU 5
  • ACU 0
  • Target Price
  • CRBU $11.80
  • ACU N/A
  • AVG Volume (30 Days)
  • CRBU 1.6M
  • ACU 8.7K
  • Earning Date
  • CRBU 03-10-2025
  • ACU 02-28-2025
  • Dividend Yield
  • CRBU N/A
  • ACU 1.61%
  • EPS Growth
  • CRBU N/A
  • ACU 188.89
  • EPS
  • CRBU N/A
  • ACU 4.84
  • Revenue
  • CRBU $11,475,000.00
  • ACU $190,488,947.00
  • Revenue This Year
  • CRBU N/A
  • ACU $0.61
  • Revenue Next Year
  • CRBU N/A
  • ACU $4.86
  • P/E Ratio
  • CRBU N/A
  • ACU $7.68
  • Revenue Growth
  • CRBU N/A
  • ACU N/A
  • 52 Week Low
  • CRBU $1.50
  • ACU $32.85
  • 52 Week High
  • CRBU $8.33
  • ACU $50.69
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 34.82
  • ACU 48.20
  • Support Level
  • CRBU $1.50
  • ACU $36.00
  • Resistance Level
  • CRBU $1.69
  • ACU $37.32
  • Average True Range (ATR)
  • CRBU 0.13
  • ACU 1.07
  • MACD
  • CRBU -0.01
  • ACU 0.34
  • Stochastic Oscillator
  • CRBU 3.70
  • ACU 75.13

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

Share on Social Networks: